The finding of universal seropositivity for circulating YB-1/p18 fragments may be explained by similar widespread YB-1 positivity in tissue samples of cancer patients[2,4,17], emphasizing that YB-1 dysregulation is a common feature found in tumor tissue. Here, YBX1 is linked to cancer.